MPL (MPL Proto-oncogene, Thrombopoietin Receptor) Gene Mutation Analysis
MPL gene is located on the short arm of chromosome 1 at position p34.2 and encodes for the thrombopoietin receptor protein, CD110 which consists of 635 amino acids. CD110 is a transmembrane protein and activates the proliferation and growth of cells, in particular megakaryocytes, through the JAK/STAT pathway, thus increasing platelet synthesis. Thrombopoietin is the ligand that binds and stimulates CD110. Mutations in the MPL gene account for approximately 5% of cases of the myeloproliferative disorder Essential thrombocytosis.
The most common mutation in this gene is Ser505Asn, where serine on the 505th position is replaced by asparagine causing essential thrombocythemia. Here, the receptor for thrombopoietin is defective or absent leading to excessive formation and release of platelets from the bone marrow. Prolonged activation of compensatory reflexes increases the risk of thrombotic events and can cause neoplastic proliferation of the entire myeloid lineages resulting in myeloid leukemia.
Another but less common mutation is the W515 mutation where tryptophan at position 515 is replaced probably by leucine and is associated with primary myelofibrosis. It is characterized by abnormal megakaryocytes and stimulation of bone marrow stromal cells to release collagen causing fibrosis of the bone marrow. Such patients may progress to pancytopenia. A rare condition, congenital amegakaryocytic thrombocytopenia where there is a deficient number of megakaryocytes and platelets, is also associated with MPL mutations.
- As an aid in diagnosis of Essential thrombocythemia
- As an aid in diagnosis of bleeding or clotting disorders (thrombocythemia)
- As an aid in diagnosis of marrow fibrosis
A positive result indicates the presence of mutations or pathogenic variants in the MPL gene.
A negative result indicates the absence of mutations or pathogenic variants in the MPL gene.
Negative for mutations analysis (no mutations or pathogenic variants detected)
Polymerase Chain Reaction (PCR), Next-generation sequencing (NGS).
Whole blood (EDTA) or bone marrow.
Stability
- Ambient: 24 hrs.
- Refrigerated: 3 days
- Frozen: Unstable
- Curr Opin Hematol. 1995; 9:331-8 [PMID: 9372016]
- Int Rev Cell Mol Biol. 2021; 365:163-178 [PMID: 34756243]
- Transfus Sci. 1997; 3:129-37 [PMID: 10174280]
- Br J Haematol. 1996; 1:60-6 [PMID: 8562412]